Skip to content

Elucidation of gaze cognitive and social cognitive characteristics of autism spectrum disorder by magnetoencephalography (MEG) measurement

Elucidation of gaze cognitive and social cognitive characteristics of autism spectrum disorder by magnetoencephalography (MEG) measurement - Elucidation of gaze cognitive and social cognitive characteristics of autism spectrum disorder by magnetoencephalography (MEG) measurement

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000047962
Enrollment
60
Registered
2022-06-06
Start date
2019-12-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorder

Interventions

None listed

Sponsors

Department of Community Psychiatric Medicine, Niigata University Graduate School of Medical and Dental Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Enroll in 30 ASD patients aged 20 years or older with no intellectual disability and borderline intelligence (ie IQ 85 or higher) and 30 neurotypical (TD) groups matched by age, gender, and IQ. For the diagnosis of ASD, the 5th edition (DSM-5) of the Diagnosis and Statistics Manual for Mental Illness is used, and the diagnosis is made with the unanimous agreement of two psychiatrists who have been examined separately. For IQ evaluation, use WAIS-III or WAIS-IV, and enter after confirming that FIQ85 or higher and that there is no problem in language comprehension (VIQ85 or higher).

Exclusion criteria

Exclusion criteria: In order to exclude the effects of secondary disorders, cases of coexisting mental illness such as schizophrenia and depression are excluded. We do not exclude abnormalities in the developmental disability zone that are often associated with ASD, such as lack of attention / hyperactivity, localized learning disabilities, communal motor disorders, tic disorders, and Tourette's disorders, and are thought to be inherent in the patient.

Design outcomes

Primary

MeasureTime frame
Activity of related brain regions by magnetoencephalography measurement

Countries

Japan

Contacts

Public ContactAtsunori Sugimoto

Niigata University Graduate School of Medical and Dental Sciences Department of Community Psychiatric Medicine

sugimoto.pedpsy@gmail.com0258-227-2213

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026